Key Findings:
- Picolinic acid has the ability to disrupt the entry of enveloped viruses into the host’s cell and prevent infection.
- Researchers hope to develop the compound into a broad-spectrum therapeutic that can help fight against a variety of viral diseases.
- Picolinic acid exhibits antiviral activity and can slow down viral entry into host cells.
- The compound specifically blocks the fusion of enveloped viruses with the host cell membrane, making it effective against a variety of enveloped viruses.
- Picolinic acid has minimal effect on the host cell and causes permanent damage to the virus.
- Testing in animal models showed that the compound protected animals from infection and reduced viral load in the lungs.
- Researchers are seeking partnerships with pharmaceutical industries to facilitate the clinical development of the compound.
According to the study, picolinic acid not only helps in the absorption of zinc and other trace elements from the gut but also exhibits antiviral activity. The compound disrupts the fusion of enveloped viruses with the host cell membrane, preventing viral entry and replication. This makes it effective against a variety of enveloped viruses, including SARS-CoV-2 and influenza A viruses.
Unlike traditional antiviral drugs that target the virus directly or some part of the host cell, picolinic acid targets a host-derived component of the virus. Since viruses borrow this component from the host, they are unable to repair the damage to their envelope, resulting in permanent damage to the virus. This mechanism reduces the risk of drug resistance and negative side effects on the host cell.
In animal models, picolinic acid protected animals from infection and reduced viral load in the lungs. The compound also led to an increase in immune cells in the animals, indicating its potential to enhance the immune response against viral infections.
The researchers are now focused on enhancing the compound’s efficacy, stability, and absorption in the host body. They are seeking partnerships with pharmaceutical industries to facilitate its clinical development and use against present and future viral outbreaks.
Follow DelhiBreakings on Google News
Superfast News Coverage by DelhiBreakings.com team.
For Superfast national news and Delhi Breaking Stories visit us daily at https://delhibreakings.com
